Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Dupilumab for eczema may cause hair loss.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Some drugs used to treat immune conditions may cause different types of hair loss.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Type I interferons play a key role in the development of various skin diseases.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Platelet-rich treatments can help improve wound healing and tissue repair.

High TSPEAR levels in colorectal cancer predict worse outcomes.